GlobeNewswire Inc.··NaHemab Therapeutics Prices $301.5M IPO at $18/Share, Nasdaq Debut Set for May
Hemab Therapeutics prices $301.5M IPO at $18/share, listing on Nasdaq as $COAG starting May 1, 2026.
JEFEVRIPOclinical-stage
E
$EVR
1 article found0 positive
0 negative
1 neutral